<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03105362</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00024854</org_study_id>
    <nct_id>NCT03105362</nct_id>
  </id_info>
  <brief_title>Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome</brief_title>
  <official_title>Tolerability of an Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Entrinsic Health Solutions, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the tolerability and palatability of an amino acid based oral
      rehydration solution (enterade®) compared to current oral rehydration solution among children
      with short bowel syndrome .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with short bowel syndrome (SBS) have a critical reduction of the gut mass/function
      that is below the minimum needed to absorb nutrients and fluids required for adequate
      homeostasis. There are limited data regarding the optimal choice for oral rehydration in the
      setting of SBS that can maximize fluid absorption in the setting of diarrhea with limited
      intestinal absorptive surface area. The investigators propose a preliminary open label single
      center study assessing tolerability and palatability of enterade® ( an amino acid (AA) based
      oral rehydrating solution (ORS)) and compare to baseline. Eligible patients with SBS will
      participate in a 14-day trial monitoring and measuring tolerability and palatability of an
      AA-ORS, enterade®, in addition to their regular diet.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 16, 2017</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Open label single center pilot study</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stool output</measure>
    <time_frame>14 days</time_frame>
    <description>Ostomy output measured as milliliters per day (participants who have an ostomy) or frequency (participants who have intestinal continuity).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerance: Incidence of abdominal distention and emesis</measure>
    <time_frame>14 days</time_frame>
    <description>Incidence of abdominal distention and emesis.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Palatability on the 100-mm visual analog scale</measure>
    <time_frame>14 days</time_frame>
    <description>Rating of enterade® taste compared to previous oral rehydration solution comparing measurements on the 100-mm visual analog scale. The facial hedonic method. (worst (0mm), best taste(100mm)).</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Short Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>AA ORS arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will consume commercially amino acid based oral rehydration solution (enterade®).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Enterade® oral rehydration solution</intervention_name>
    <description>Commercially available amino acid based oral rehydration solution</description>
    <arm_group_label>AA ORS arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients with a diagnosis of short bowel syndrome (as defined by
             surgical therapy for congenital or acquired gastrointestinal disease) between the ages
             of 1-17

          -  Patients who are in intestinal continuity or with diverting ileostomy, jejunostomy

          -  Patients must be on a stable enteral nutrition regimen with oral rehydration fluids
             that are taken orally.

          -  Stable GI medication regimen (e.g., loperamide, cholestyramine, small bowel bacterial
             overgrowth (SBBO) regimen)

        Exclusion Criteria:

          -  Patients receiving IV antibiotics within the previous 72h.

          -  Patients with a primary diagnosis of a motility disorder (e.g., chronic intestinal
             pseudo-obstruction) or epithelial cell disorder (e.g., microvillus inclusion disease)

          -  Malnourished (as defined by Weight/Height Z-score (WHZ) &lt;-2)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christopher P Duggan, MD</last_name>
    <phone>617-355-7612</phone>
    <email>Christopher.Duggan@childrens.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lissette Jimenez, MD</last_name>
    <phone>617-355-4806</phone>
    <email>Lissette.Jimenez@childrens.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christopher P Duggan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Freedman SB, Cho D, Boutis K, Stephens D, Schuh S. Assessing the palatability of oral rehydration solutions in school-aged children: a randomized crossover trial. Arch Pediatr Adolesc Med. 2010 Aug;164(8):696-702. doi: 10.1001/archpediatrics.2010.129.</citation>
    <PMID>20679159</PMID>
  </reference>
  <reference>
    <citation>Modi BP, Langer M, Ching YA, Valim C, Waterford SD, Iglesias J, Duro D, Lo C, Jaksic T, Duggan C. Improved survival in a multidisciplinary short bowel syndrome program. J Pediatr Surg. 2008 Jan;43(1):20-4. doi: 10.1016/j.jpedsurg.2007.09.014.</citation>
    <PMID>18206449</PMID>
  </reference>
  <reference>
    <citation>Gosselin KB, Duggan C. Enteral nutrition in the management of pediatric intestinal failure. J Pediatr. 2014 Dec;165(6):1085-90. doi: 10.1016/j.jpeds.2014.08.012. Epub 2014 Sep 18. Review.</citation>
    <PMID>25242686</PMID>
  </reference>
  <reference>
    <citation>King CK, Glass R, Bresee JS, Duggan C; Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003 Nov 21;52(RR-16):1-16.</citation>
    <PMID>14627948</PMID>
  </reference>
  <reference>
    <citation>Faruque AS, Mahalanabis D, Hamadani J, Hoque SS. Hypo-osmolar sucrose oral rehydration solutions in acute diarrhoea: a pilot study. Acta Paediatr. 1996 Oct;85(10):1247-8.</citation>
    <PMID>8922094</PMID>
  </reference>
  <reference>
    <citation>World Health Organization. Oral rehydration salts (ORS): A new reduced osmolarity formulation. Geneva: WHO, 2002 Contract No.: September 23, 2002.</citation>
  </reference>
  <reference>
    <citation>Santosham M, Burns BA, Reid R, Letson GW, Duncan B, Powlesland JA, Foster S, Garrett S, Croll L, Nyunt Nyunt W, et al. Glycine-based oral rehydration solution: reassessment of safety and efficacy. J Pediatr. 1986 Nov;109(5):795-801.</citation>
    <PMID>3534198</PMID>
  </reference>
  <reference>
    <citation>Lima AA, Carvalho GH, Figueiredo AA, Gifoni AR, Soares AM, Silva EA, Guerrant RL. Effects of an alanyl-glutamine-based oral rehydration and nutrition therapy solution on electrolyte and water absorption in a rat model of secretory diarrhea induced by cholera toxin. Nutrition. 2002 Jun;18(6):458-62.</citation>
    <PMID>12044816</PMID>
  </reference>
  <reference>
    <citation>Nightingale JM. The Sir David Cuthbertson Medal Lecture. Clinical problems of a short bowel and their treatment. Proc Nutr Soc. 1994 Jul;53(2):373-91. Review.</citation>
    <PMID>7972152</PMID>
  </reference>
  <reference>
    <citation>Lennard-Jones JE. Oral rehydration solutions in short bowel syndrome. Clin Ther. 1990;12 Suppl A:129-37; discussion 138. Review.</citation>
    <PMID>2187606</PMID>
  </reference>
  <reference>
    <citation>Nightingale J, Woodward JM; Small Bowel and Nutrition Committee of the British Society of Gastroenterology. Guidelines for management of patients with a short bowel. Gut. 2006 Aug;55 Suppl 4:iv1-12.</citation>
    <PMID>16837533</PMID>
  </reference>
  <reference>
    <citation>Radlović V, Leković Z, Radlović N, Lukac M, Ristić D, Simić D, Bijelić M. Significance of the application of oral rehydration solution to maintain water and electrolyte balance in infants with ileostomy. Srp Arh Celok Lek. 2013 May-Jun;141(5-6):325-8.</citation>
    <PMID>23858801</PMID>
  </reference>
  <reference>
    <citation>Yin L, Gupta R, Vaught L, Grosche A, Okunieff P, Vidyasagar S. An amino acid-based oral rehydration solution (AA-ORS) enhanced intestinal epithelial proliferation in mice exposed to radiation. Sci Rep. 2016 Nov 23;6:37220. doi: 10.1038/srep37220.</citation>
    <PMID>27876791</PMID>
  </reference>
  <reference>
    <citation>Ching YA, Modi BP, Jaksic T, Duggan C. High diagnostic yield of gastrointestinal endoscopy in children with intestinal failure. J Pediatr Surg. 2008 May;43(5):906-10. doi: 10.1016/j.jpedsurg.2007.12.037.</citation>
    <PMID>18485964</PMID>
  </reference>
  <reference>
    <citation>Duro D, Kalish LA, Johnston P, Jaksic T, McCarthy M, Martin C, Dunn JC, Brandt M, Nobuhara KK, Sylvester KG, Moss RL, Duggan C. Risk factors for intestinal failure in infants with necrotizing enterocolitis: a Glaser Pediatric Research Network study. J Pediatr. 2010 Aug;157(2):203-208.e1. doi: 10.1016/j.jpeds.2010.02.023. Epub 2010 May 6.</citation>
    <PMID>20447649</PMID>
  </reference>
  <reference>
    <citation>Hull MA, Jones BA, Zurakowski D, Raphael B, Lo C, Jaksic T, Duggan C. Low serum citrulline concentration correlates with catheter-related bloodstream infections in children with intestinal failure. JPEN J Parenter Enteral Nutr. 2011 Mar;35(2):181-7. doi: 10.1177/0148607110381406.</citation>
    <PMID>21378247</PMID>
  </reference>
  <reference>
    <citation>Squires RH, Duggan C, Teitelbaum DH, Wales PW, Balint J, Venick R, Rhee S, Sudan D, Mercer D, Martinez JA, Carter BA, Soden J, Horslen S, Rudolph JA, Kocoshis S, Superina R, Lawlor S, Haller T, Kurs-Lasky M, Belle SH; Pediatric Intestinal Failure Consortium. Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium. J Pediatr. 2012 Oct;161(4):723-8.e2. doi: 10.1016/j.jpeds.2012.03.062. Epub 2012 May 11.</citation>
    <PMID>22578586</PMID>
  </reference>
  <reference>
    <citation>Khan FA, Squires RH, Litman HJ, Balint J, Carter BA, Fisher JG, Horslen SP, Jaksic T, Kocoshis S, Martinez JA, Mercer D, Rhee S, Rudolph JA, Soden J, Sudan D, Superina RA, Teitelbaum DH, Venick R, Wales PW, Duggan C; Pediatric Intestinal Failure Consortium. Predictors of Enteral Autonomy in Children with Intestinal Failure: A Multicenter Cohort Study. J Pediatr. 2015 Jul;167(1):29-34.e1. doi: 10.1016/j.jpeds.2015.03.040. Epub 2015 Apr 25.</citation>
    <PMID>25917765</PMID>
  </reference>
  <reference>
    <citation>Fullerton BS, Sparks EA, Hall AM, Duggan C, Jaksic T, Modi BP. Enteral autonomy, cirrhosis, and long term transplant-free survival in pediatric intestinal failure patients. J Pediatr Surg. 2016 Jan;51(1):96-100. doi: 10.1016/j.jpedsurg.2015.10.027. Epub 2015 Oct 23.</citation>
    <PMID>26561248</PMID>
  </reference>
  <reference>
    <citation>Fayad IM, Hashem M, Duggan C, Refat M, Bakir M, Fontaine O, Santosham M. Comparative efficacy of rice-based and glucose-based oral rehydration salts plus early reintroduction of food. Lancet. 1993 Sep 25;342(8874):772-5.</citation>
    <PMID>8103876</PMID>
  </reference>
  <reference>
    <citation>Santosham M, Fayad I, Abu Zikri M, Hussein A, Amponsah A, Duggan C, Hashem M, el Sady N, Abu Zikri M, Fontaine O. A double-blind clinical trial comparing World Health Organization oral rehydration solution with a reduced osmolarity solution containing equal amounts of sodium and glucose. J Pediatr. 1996 Jan;128(1):45-51.</citation>
    <PMID>8551420</PMID>
  </reference>
  <reference>
    <citation>Duggan C, Lasche J, McCarty M, Mitchell K, Dershewitz R, Lerman SJ, Higham M, Radzevich A, Kleinman RE. Oral rehydration solution for acute diarrhea prevents subsequent unscheduled follow-up visits. Pediatrics. 1999 Sep;104(3):e29.</citation>
    <PMID>10469812</PMID>
  </reference>
  <reference>
    <citation>Duggan C, Fontaine O, Pierce NF, Glass RI, Mahalanabis D, Alam NH, Bhan MK, Santosham M. Scientific rationale for a change in the composition of oral rehydration solution. JAMA. 2004 Jun 2;291(21):2628-31.</citation>
    <PMID>15173155</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2017</study_first_submitted>
  <study_first_submitted_qc>April 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2017</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children’s Hospital</investigator_affiliation>
    <investigator_full_name>Christopher Duggan</investigator_full_name>
    <investigator_title>Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Oral Rehydration Solutions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Short Bowel Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <study_docs>
    <study_doc>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://www.childrenshospital.org/research-and-innovation/research/research-administration/office-of-clinical-investigation</doc_url>
      <doc_comment>For further details contact Lissette Jimenez, MD Email: lissette.jimenez@childrens.harvard.edu</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

